New🔥TCR #CRISPR✂️ cancer #immunotherapy paper just out in nature by PACT Pharma & UCLA. Why all the 📸headlines & press coverage? This small proof-of-concept study can give us a glimpse into the future of cancer therapy. Let’s unpack the details & relevance of this study👇🧵

Providing real-time cost feedback to surgical teams in the OR using AssistIQ software generates cost savings for thoracoscopic lobectomy. Similar savings may be possible for other surgical procedures. ow.ly/31Sk50LIh83 Gabriel Dayan Moishe Liberman Brian J Potter

In this #AuthorVideo, Moishe Liberman discusses his recent article, "Surgical Cost Awareness Program Study: Impact of a Novel, Real-Time, Cost Awareness Intervention on Operating Room Expenses in Thoracoscopic Lobectomy." Gabriel Dayan Brian J Potter ow.ly/nRWN50LSIc3

Good luck to all my peers from Canadian medical schools who submitted their CARMS applications today! You got this 😉

Une étude clinique qui pourrait révolutionner les soins aux personnes atteintes de tumeurs métastatiques aux poumons. Bravo Dr Moishe Liberman et son équipe 👏

Teamwork in the OR 🤝

#SAGES2023 #sharktankwinner OR carbon foot print is a real thing! AssistIQ may also help decrease patient care cost by being more efficient with what we use in the operating room Antonio Caycedo-Marulanda MD, MSc.

Excellent job by the CSOHNS Canadian Head & Neck Collaborative Large oral cavity database with 8 high volume centers Faculté de médecine - great leaders in this study Award winning work !

Great national collaborative work and wonderful presentation AHNS #AHNS2023 by Gabriel Dayan with mentorship by the uMontreal News team Houda Bahig, MD PhD

Such an honour presenting this multicenter study from the CSOHNS Head & Neck Collaborative Research Initiative @ #AHNS2023. 1. Delays to post-op RT are prevalent in Canada. 2. Such delays are associated with significantly worse overall survival. Have a read in JAMA Otolaryngology – Head & Neck Surgery

1⃣ Dr. Houda Bahig (Centre de recherche du CHUM / Montreal) will use artificial intelligence to advance precision medicine for patients with head and neck cancers 2⃣ Dr. Long Viet Nguyen (Princess Margaret Cancer Centre / Toronto) will seek to predict response to treatments for triple-negative breast cancer

Honoured to have been invited to speak at the white coat ceremony 👨‍⚕️ for first year medical student Faculté de médecine. Félicitations à la cohorte 2027!

In this multicenter cohort study of patients with oral cavity cancer requiring surgery & radiation therapy in Canada, failure to initiate adjuvant radiation therapy within six weeks was assoc with worse overall survival and disease-free survival. ja.ma/3ug2wd9

Nivolumab showed potential clinical activity in this immune checkpoint therapy trial for high-risk oral precancerous disease. Future trials should prioritize cancer-free survival end points and biomarker stratification ja.ma/3MHpro3

Fresh off the press! Excited to share our most recent publication identifying modifiable reasons for treatment delays in oral cavity cancer. One step closer to achieving timely completion of treatment intervals. Centre de recherche du CHUM Houda Bahig, MD PhD sciencedirect.com/science/articl…

Prefabricated fibular free flaps are as safe, effective, and accurate as bone-driven and delayed osseointegrated implant installation for jaw reconstruction while achieving significantly faster oral rehabilitation (12 vs 60 months). ja.ma/3JMCQJT

Most viewed in the last 7 days from JAMA Otolaryngology – Head & Neck Surgery: Study examines association of posttreatment circulating tumor HPV DNA with residual disease and 2-year overall survival and recurrence-free survival in patients with HPV-associated head and neck cancer. ja.ma/49ZihVe

merck.com/news/mercks-ke… Robert Haddad Glenn J. Hanna, M.D. R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) Robert Ferris, MD, PhD Nabil Saba, MD Schmitt Lab Jonathan Schoenfeld Dr. Gavin P. Dunn Toni Choueiri, MD Kartik Sehgal

Among patients with oral cavity squamous cell carcinoma, preoperative clinical and tumor characteristics can adequately identify patients who are more likely to receive adjuvant therapy. ja.ma/4c4Txxk CSO HNS Collaborative Research Initiative Gabriel Dayan Antoine Eskander MD ScM John De Almeida

Reclassifying each N category 1 stratum higher for imaging-detected extranodal extension-positive disease resulted in better disease-free and overall survival in patients human papillomavirus–positive oropharyngeal carcinoma. ja.ma/4k0TANm Melvin LK CHUA | FRCR, PhD, FASCO